• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.JunD和JunB整合前列腺素E2对乳腺癌相关近端芳香化酶启动子的激活作用。
Mol Endocrinol. 2011 May;25(5):767-75. doi: 10.1210/me.2010-0368. Epub 2011 Mar 10.
2
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.前列腺素E(2)通过激活脂肪成纤维细胞中的p38和c-Jun氨基末端激酶诱导乳腺癌相关芳香化酶启动子。
Cancer Res. 2007 Sep 15;67(18):8914-22. doi: 10.1158/0008-5472.CAN-06-4751.
3
A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.丁酸钠通过破坏乳腺脂肪成纤维细胞中的转录复合物在癌症相关芳香化酶启动子I.3和II调控中的新作用。
J Biol Chem. 2006 Feb 3;281(5):2585-97. doi: 10.1074/jbc.M508498200. Epub 2005 Nov 21.
4
Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.恶性乳腺上皮细胞通过启动子II刺激人脂肪成纤维细胞中的芳香化酶表达:一种由CCAAT/增强子结合蛋白β介导的乳腺肿瘤上皮-间质相互作用。
Cancer Res. 2001 Mar 1;61(5):2328-34.
5
Regulation of aromatase expression in breast cancer tissue.乳腺癌组织中芳香化酶表达的调控。
Ann N Y Acad Sci. 2009 Feb;1155:121-31. doi: 10.1111/j.1749-6632.2009.03705.x.
6
BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.BRCA1在乳腺脂肪成纤维细胞和恶性上皮细胞中对癌症相关的芳香化酶启动子I.3和II起负调控作用。
J Clin Endocrinol Metab. 2006 Nov;91(11):4514-9. doi: 10.1210/jc.2006-1364. Epub 2006 Aug 29.
7
EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.EP2和EP4受体调节人脂肪细胞和乳腺癌细胞中的芳香化酶表达。BRCA1与p300交换的证据。
J Biol Chem. 2008 Feb 8;283(6):3433-3444. doi: 10.1074/jbc.M705409200. Epub 2007 Dec 14.
8
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.低氧诱导因子-1α刺激前列腺素E2驱动的乳腺脂肪基质中芳香化酶的表达。
Breast Cancer Res. 2013 Apr 8;15(2):R30. doi: 10.1186/bcr3410.
9
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.人类CYP19(芳香化酶P450)基因:启动子的生理作用和基因组组织的最新进展
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):219-24. doi: 10.1016/s0960-0760(03)00359-5.
10
Aromatase activity induction in human adipose fibroblasts by retinoic acids via retinoic acid receptor α.视黄酸通过视黄酸受体 α 诱导人脂肪成纤维细胞芳香酶活性。
J Mol Endocrinol. 2013 Sep 10;51(2):247-60. doi: 10.1530/JME-12-0129. Print 2013 Oct.

引用本文的文献

1
Obesity, Diabetes, and Increased Cancer Progression.肥胖、糖尿病与癌症恶化。
Diabetes Metab J. 2021 Nov;45(6):799-812. doi: 10.4093/dmj.2021.0077. Epub 2021 Nov 22.
2
Aromatase expression and regulation in breast and endometrial cancer.芳香化酶在乳腺癌和子宫内膜癌中的表达与调控
J Mol Endocrinol. 2016 Jul;57(1):R19-33. doi: 10.1530/JME-15-0310. Epub 2016 Apr 11.
3
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.肥胖与乳腺癌:分子关联及潜在临床应用
Oncologist. 2016 Apr;21(4):404-17. doi: 10.1634/theoncologist.2015-0351. Epub 2016 Feb 10.
4
Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.肥胖相关的全身白细胞介素-6通过增加乳腺癌细胞前列腺素E2的产生来促进前脂肪细胞芳香化酶的表达。
Breast Cancer Res Treat. 2015 Jan;149(1):49-57. doi: 10.1007/s10549-014-3223-0. Epub 2014 Dec 5.
5
Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis.染色质组动力学的定量分析揭示了HP1BP3在缺氧诱导的肿瘤发生中的新作用。
Mol Cell Proteomics. 2014 Dec;13(12):3236-49. doi: 10.1074/mcp.M114.038232. Epub 2014 Aug 6.
6
Impact of obesity on mammary gland inflammation and local estrogen production.肥胖对乳腺炎症和局部雌激素产生的影响。
J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):183-9. doi: 10.1007/s10911-014-9321-0. Epub 2014 Jun 17.
7
Glucocorticoid-induction of hypothalamic aromatase via its brain-specific promoter.糖皮质激素通过其脑特异性启动子诱导下丘脑芳香化酶。
Mol Cell Endocrinol. 2012 Oct 15;362(1-2):85-90. doi: 10.1016/j.mce.2012.05.012. Epub 2012 Jun 13.
8
Weight gain increases human aromatase expression in mammary gland.体重增加会增加人类乳腺中的芳香酶表达。
Mol Cell Endocrinol. 2012 May 15;355(1):114-20. doi: 10.1016/j.mce.2012.01.027. Epub 2012 Feb 10.
9
Aromatase, breast cancer and obesity: a complex interaction.芳香化酶、乳腺癌与肥胖:复杂的相互作用。
Trends Endocrinol Metab. 2012 Feb;23(2):83-9. doi: 10.1016/j.tem.2011.10.003. Epub 2011 Dec 12.

本文引用的文献

1
Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.环磷酸腺苷反应元件结合蛋白调节转录共激活因子2的亚细胞定位揭示了绝经后女性肥胖与乳腺癌之间的联系。
Cancer Res. 2009 Jul 1;69(13):5392-9. doi: 10.1158/0008-5472.CAN-09-0108. Epub 2009 Jun 9.
2
Regulation of breast cancer-associated aromatase promoters.乳腺癌相关芳香化酶启动子的调控
Cancer Lett. 2009 Jan 8;273(1):15-27. doi: 10.1016/j.canlet.2008.05.038. Epub 2008 Jul 9.
3
Characterisation of aromatase expression in the human adipocyte cell line SGBS.人脂肪细胞系SGBS中芳香化酶表达的特征分析。
Breast Cancer Res Treat. 2008 Dec;112(3):429-35. doi: 10.1007/s10549-007-9883-2. Epub 2008 Jan 5.
4
Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.前列腺素E(2)通过激活脂肪成纤维细胞中的p38和c-Jun氨基末端激酶诱导乳腺癌相关芳香化酶启动子。
Cancer Res. 2007 Sep 15;67(18):8914-22. doi: 10.1158/0008-5472.CAN-06-4751.
5
Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.针对雌激素受体用于治疗和预防乳腺癌的疗法的发展与演变。
Steroids. 2007 Jan;72(1):7-25. doi: 10.1016/j.steroids.2006.10.009. Epub 2006 Dec 13.
6
Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.JNK的用途:c-Jun氨基末端激酶的众多不同底物
Microbiol Mol Biol Rev. 2006 Dec;70(4):1061-95. doi: 10.1128/MMBR.00025-06.
7
A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.丁酸钠通过破坏乳腺脂肪成纤维细胞中的转录复合物在癌症相关芳香化酶启动子I.3和II调控中的新作用。
J Biol Chem. 2006 Feb 3;281(5):2585-97. doi: 10.1074/jbc.M508498200. Epub 2005 Nov 21.
8
Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer.人乳腺癌中源自不同启动子(I.4、I.3、PII和I.7)的芳香化酶mRNA表达的定量分析及其与TNF-α、IL-6和COX-2 mRNA表达的关联。
Int J Cancer. 2006 Apr 15;118(8):1915-21. doi: 10.1002/ijc.21562.
9
Choosing between an aromatase inhibitor and tamoxifen in the adjuvant setting.在辅助治疗中选择芳香化酶抑制剂与他莫昔芬。
Curr Opin Oncol. 2005 Nov;17(6):559-65. doi: 10.1097/01.cco.0000180434.31991.bf.
10
Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.雌激素反应性乳腺和子宫疾病中芳香化酶表达的调控:从实验台到治疗
Pharmacol Rev. 2005 Sep;57(3):359-83. doi: 10.1124/pr.57.3.6.

JunD和JunB整合前列腺素E2对乳腺癌相关近端芳香化酶启动子的激活作用。

JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.

作者信息

Chen Dong, Reierstad Scott, Fang Feng, Bulun Serdar E

机构信息

Division of Reproductive Biology Research, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.

出版信息

Mol Endocrinol. 2011 May;25(5):767-75. doi: 10.1210/me.2010-0368. Epub 2011 Mar 10.

DOI:10.1210/me.2010-0368
PMID:21393445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3082330/
Abstract

Aromatase is the key enzyme in estrogen biosynthesis. Normal breast adipose tissue expresses low levels of aromatase via the distal promoter I.4. Breast adipose tissue surrounding a tumor exhibits excessive aromatase expression controlled by proximal aromatase promoters I.3/II, leading to high local levels of estrogen and breast cancer progression. Prostaglandin E(2) (PGE(2)) secreted by malignant breast epithelial cells activates breast cancer-associated aromatase promoters I.3/II, but silences promoter I.4, in cultured human breast adipose fibroblasts (BAF). The c-Jun N-terminal kinase 1 and p38α mitogen activated protein kinases are necessary for PGE(2) activation of aromatase promoters I.3/II; thus, we examined the roles of downstream targets, c-Jun, JunB, JunD, and activating transcription factor 2, in PGE(2)-mediated regulation of aromatase expression in BAF. PGE(2) induced JunB and JunD protein expression through protein kinase A and protein kinase C, respectively. JunB or JunD knockdown by small interfering RNA markedly reduced PGE(2)-induced total aromatase mRNA level and enzyme activity via promoters I.3/II. JunB knockdown also abrogated JunD expression. JunB stimulated, whereas JunD inhibited, aromatase promoter I.4 activity. Activating transcription factor 2 knockdown did not affect promoter-specific or total aromatase mRNA levels. c-Jun knockdown increased promoter I.4-specific and PGE(2)-induced promoters I.3/II-specific aromatase mRNA levels, leading to enhanced PGE(2)-induced total aromatase mRNA level and enzyme activity. JunD, c-Jun, and JunB bound to a CRE(-211/-199) essential for PGE(2) induction of aromatase promoters I.3/II. Taken together, JunD and c-Jun repress aromatase promoter I.4. JunD mediates, whereas c-Jun modulates, PGE(2) activation of aromatase promoters I.3/II via CRE(-211/-199). JunB also activates aromatase promoters I.3/II by maintaining JunD expression. Targeting JunD may abolish aromatase expression selectively in breast cancer tissue.

摘要

芳香化酶是雌激素生物合成中的关键酶。正常乳腺脂肪组织通过远端启动子I.4表达低水平的芳香化酶。肿瘤周围的乳腺脂肪组织表现出由近端芳香化酶启动子I.3/II控制的过度芳香化酶表达,导致局部高水平的雌激素和乳腺癌进展。恶性乳腺上皮细胞分泌的前列腺素E(2)(PGE(2))在培养的人乳腺脂肪成纤维细胞(BAF)中激活与乳腺癌相关的芳香化酶启动子I.3/II,但使启动子I.4沉默。c-Jun氨基末端激酶1和p38α丝裂原活化蛋白激酶是PGE(2)激活芳香化酶启动子I.3/II所必需的;因此,我们研究了下游靶点c-Jun、JunB、JunD和激活转录因子2在PGE(2)介导的BAF中芳香化酶表达调控中的作用。PGE(2)分别通过蛋白激酶A和蛋白激酶C诱导JunB和JunD蛋白表达。通过小干扰RNA敲低JunB或JunD可显著降低PGE(2)通过启动子I.3/II诱导的总芳香化酶mRNA水平和酶活性。敲低JunB也消除了JunD的表达。JunB刺激而JunD抑制芳香化酶启动子I.4的活性。敲低激活转录因子2不影响启动子特异性或总芳香化酶mRNA水平。敲低c-Jun增加了启动子I.4特异性和PGE(2)诱导的启动子I.3/II特异性芳香化酶mRNA水平,导致PGE(2)诱导的总芳香化酶mRNA水平和酶活性增强。JunD、c-Jun和JunB与PGE(2)诱导芳香化酶启动子I.3/II所必需的CRE(-211/-199)结合。综上所述,JunD和c-Jun抑制芳香化酶启动子I.4。JunD介导而c-Jun调节PGE(2)通过CRE(-211/-199)对芳香化酶启动子I.3/II的激活。JunB也通过维持JunD的表达来激活芳香化酶启动子I.3/II。靶向JunD可能会选择性地消除乳腺癌组织中的芳香化酶表达。